Krueger Christopher W
Officer at VTYX; SVP & CBO at INTRABIOTICS PHARMACEUTICALS INC /DE
- Sold, on record
- $7.4M
- Dollars the filings state
- Form 4 sales
- 23
- Latest Apr 2, 2024
- Form 144 notices
- 8
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- VTYXVentyx Biosciences, Inc.Officer
- INTRABIOTICS PHARMACEUTICALS INC /DESVP & CBO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- VTYX195,598 shares
- INTRABIOTICS PHARMACEUTICALS INC /DE66,706 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice VTYXNoticeSep 5, 2023 2023
Filed to sell 15,000 shares ($506k)
Krueger Christopher W, Officer
10b5-1 plan1x usual sizeFiling
- 2 Form 4 sale VTYXNo planSep 5, 2023 same day
Sold 15,000 shares at $32.61 ($489k)
Krueger Christopher W, Chief Business Officer
No 10b5-1 planSold 5.1% of holdings ($9.5M position)276,548 shares left1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice VTYXNoticeOct 3, 2023 +28 days
Filed to sell 15,000 shares ($468k)
Krueger Christopher W, Officer
10b5-1 plan1x usual sizeFiling
- 4 Form 4 sale VTYXNo planOct 3, 2023 same day
Sold 15,000 shares at $29.98 ($450k)
Krueger Christopher W, Chief Business Officer
No 10b5-1 planSold 5.1% of holdings ($8.7M position)276,548 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice VTYXNoticeDec 20, 2023 +78 days
Filed to sell 5,293 shares ($11k)
Krueger Christopher W, Officer
No 10b5-1 plan0.4x usual sizeFiling
- 6 Form 4 sale VTYXNo planDec 20, 2023 same day
Sold 5,293 shares at $2.12 ($11k)
Krueger Christopher W, Chief Business Officer
No 10b5-1 planSold 1.8% of holdings ($609k position)282,119 shares left0.4x usual sizeFollows a Form 144Filing
- 7 Form 144 notice VTYXNoticeApr 2, 2024 +104 days
Filed to sell 1,651 shares ($9k)
Krueger Christopher W, Officer
No 10b5-1 plan0.1x usual sizeFiling
- 8 Form 4 sale VTYXNo planApr 2, 2024 same day
Sold 1,651 shares at $5.40 ($9k)
Krueger Christopher W, CHIEF BUSINESS OFFICER
No 10b5-1 planSold 0.6% of holdings ($1.5M position)284,999 shares left0.1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (31)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | Apr 3, 2024 | VTYX | CHIEF BUSINESS OFFICER | Form 4 sale | 1,651 | $9k | 0.6% | No plan | SEC |
| Apr 2, 2024 | Apr 2, 2024 | VTYX | Officer | Form 144 notice | 1,651 | $9k | Notice | SEC | |
| Dec 20, 2023 | Dec 21, 2023 | VTYX | Chief Business Officer | Form 4 sale | 5,293 | $11k | 1.8% | No plan | SEC |
| Dec 20, 2023 | Dec 20, 2023 | VTYX | Officer | Form 144 notice | 5,293 | $11k | Notice | SEC | |
| Oct 3, 2023 | Oct 4, 2023 | VTYX | Chief Business Officer | Form 4 sale | 15,000 | $450k | 5.1% | No plan | SEC |
| Oct 3, 2023 | Oct 3, 2023 | VTYX | Officer | Form 144 notice | 15,000 | $468k | Notice | SEC | |
| Sep 5, 2023 | Sep 7, 2023 | VTYX | Chief Business Officer | Form 4 sale | 15,000 | $489k | 5.1% | No plan | SEC |
| Sep 5, 2023 | Sep 5, 2023 | VTYX | Officer | Form 144 notice | 15,000 | $506k | Notice | SEC | |
| Aug 3, 2023 | Aug 4, 2023 | VTYX | Chief Business Officer | Form 4 sale | 15,000 | $534k | 5.1% | No plan | SEC |
| Aug 3, 2023 | Aug 3, 2023 | VTYX | Officer | Form 144 notice | 15,000 | $550k | Notice | SEC | |
| Jul 3, 2023 | Jul 5, 2023 | VTYX | Chief Business Officer | Form 4 sale | 15,000 | $588k | 5.1% | No plan | SEC |
| Jul 3, 2023 | Jul 3, 2023 | VTYX | Officer | Form 144 notice | 15,000 | $492k | Notice | SEC | |
| Jun 5, 2023 | Jun 6, 2023 | VTYX | Chief Business Officer | Form 4 sale | 15,000 | $515k | 5.1% | No plan | SEC |
| Jun 5, 2023 | Jun 5, 2023 | VTYX | Officer | Form 144 notice | 15,000 | $510k | Notice | SEC | |
| May 3, 2023 | May 4, 2023 | VTYX | Chief Business Officer | Form 4 sale | 15,000 | $580k | 5.2% | No plan | SEC |
| May 3, 2023 | May 3, 2023 | VTYX | Officer | Form 144 notice | 15,000 | $566k | Notice | SEC | |
| Dec 22, 2022 | Dec 23, 2022 | VTYX | Chief Business Officer | Form 4 sale | 3,654 | $116k | 1.3% | Plan not stated | SEC |
| Dec 13, 2022 | Dec 15, 2022 | VTYX | Chief Business Officer | Form 4 sale | 30,000 | $1M | 9.9% | Plan not stated | SEC |
| Dec 2, 2022 | Dec 6, 2022 | VTYX | Chief Business Officer | Form 4 sale | 50,000 | $1.5M | 14.2% | Plan not stated | SEC |
| Apr 3, 2022 | Apr 5, 2023 | VTYX | Chief Business Officer | Form 4 sale | 15,000 | $493k | 5.2% | No plan | SEC |
| Jul 23, 2010 | Jul 26, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 3,000 | $56k | 76.3% | Unusual | SEC |
| Jun 23, 2010 | Jun 24, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 3,000 | $66k | 76.3% | Unusual | SEC |
| May 24, 2010 | May 26, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 3,000 | $69k | 76.3% | Unusual | SEC |
| May 17, 2010 | May 18, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 1,145 | $27k | 55.1% | Unusual | SEC |
| Apr 23, 2010 | Apr 26, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 3,000 | $79k | 76.3% | Unusual | SEC |
| Mar 23, 2010 | Mar 24, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 9,000 | $166k | 90.6% | Unusual | SEC |
| Dec 23, 2009 | Dec 24, 2009 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 6,000 | $91k | 86.5% | Unusual | SEC |
| Oct 23, 2009 | Oct 26, 2009 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 3,000 | $46k | 100.0% | Unusual | SEC |
| Sep 23, 2009 | Sep 24, 2009 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 3,000 | $57k | 100.0% | Unusual | SEC |
| Aug 24, 2009 | Aug 25, 2009 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 5,061 | $96k | 100.0% | Unusual | SEC |
| May 20, 2009 | May 21, 2009 | INTRABIOTICS PHARMACEUTICALS INC /DE | SVP & CBO | Form 4 sale | 27,500 | $413k | 93.0% | Unusual | SEC |